Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Allergan, Inc.    AGN   US0184901025

ALLERGAN, INC. (AGN)

43
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

Allergan, Inc. : Allergan Gets Subpoena From Government Over Lap-Band System

05/07/2012 | 06:11pm US/Eastern
   By Anjali Athavaley 
   Of  
 

Allergan Inc. (AGN) received a subpoena this month from the Department of Health and Human Services requesting documents related to the company's Lap-Band System for obesity, according to a filing.

Lap-Band is approved to help obese patients lose weight. It is inserted surgically through a small incision and placed at the top of the stomach. The inflatable band can be tightened or loosened to reduce or enlarge stomach capacity.

An Allergan spokeswoman declined to comment further.

Earlier this month, Allergan said its first-quarter earnings rose 45% on double-digit sales growth in its specialty-pharmaceuticals business. But sales in Allergan's obesity intervention category slipped 15.5% as high unemployment, lofty co-payments and rigid requirements from insurers pressured sales.

Last December, the U.S. Food and Drug Administration warned nine groups, mostly surgical centers in California, that if they continue misleading advertising for Lap-Band, they could face monetary penalties and have inventory seized. The FDA made no allegations against Allergan at the time.

Allergan shares were up fractionally to $93.79 in after-hours trading Monday. The stock is up nearly 7% so far this year.

-By Anjali Athavaley, Dow Jones Newswires; 212-416-4912; anjali.athavaley@dowjones.com

React to this article
Latest news on ALLERGAN, INC.
10m ago ALLERGAN : A much needed facelift for pharmaceuticals industry
54m ago ALLERGAN : Investor Notice: Those Who SOLD NYSE:AGN Shares Between Feb. and Apri..
3d ago ALLERGAN : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of ..
3d ago ALLERGAN : $66B Actavis-Allergan deal, Cantel Medical leadership appointment & m..
3d ago Valeant slashes stake in Allergan after losing bid
3d ago Global M&A lending hits post-crisis high
3d ago Global M&A deals cross $3 trillion for first time since 2007
3d agoDJU.S. Stock Futures Rally on China, Draghi
4d ago Valeant slashes stake in Allergan after losing bid
4d ago Valeant Pharma says may buy back up to $2 billion worth of securities
Advertisement
Chart
Duration : Period :
Allergan, Inc. Technical Analysis Chart | AGN | US0184901025 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF